Lightbridge Third Quarter 2026 Earnings & Business Update Conference Call - LIGHTBRIDGE CORP

Explicit Guidance:

• No formal financial guidance: Management explicitly declined to provide quantitative guidance for revenue, earnings, margins, or cash flow, directing listeners to the Form 10-Q for details.
• Cash Flow & Opex Trends (Forward-Looking): Anticipates continued significant multi-year capital and operating expenditures ("resource-intensive stage") to fund the Lightbridge Fuel Pilot Factory and fuel development program; expenditures expected to be phased over the pilot factory development period based on technical progress and available resources.
• Liquidity & Capital Needs: Current cash of $236.7M provides "substantial financial flexibility," but acknowledges a future requirement for additional capital to support the pilot factory and broader development; potential funding sources include strategic partnerships, government grants/contracts, and capital market transactions.

Business-Segment Outlook:

• Pilot Factory (SHED): Selected for the DOE's Nuclear Energy Launchpad I&L program; aims to design, build, and operate a dedicated manufacturing facility to produce lead test assemblies under DOE authorization (not NRC licensed) to shorten the timeline for commercial reactor demonstration.
• Commercial Scale Plant: Concurrently developing a conceptual design for the future "Lightbridge Fuel Factory" (formerly Expandable Fuel Facility) intended for commercial scale production.
• Fuel Development & Testing:
  • ATR Loop Testing: Access secured to Idaho National Laboratory's (INL) Advanced Test Reactor (ATR) loop facility for irradiating clad fuel rodlets in commercial LWR-simulated conditions; post-radiation examination of the first batch (removed May) is ongoing.
  • Future Testing Timeline: Expect to announce the first meaningful quantitative results from post-irradiation examination of the initial fuel batch in the first half of 2027.
  • Transient Testing: Future plan to test irradiated samples in INL's Transient Reactor Test Facility.
• Supply Chain: Executed a non-binding MoU with Quadrant Nuclear Industries (QNI) to discuss long-term supply of High-Assay Low-Enriched Uranium (HALU) from QNI's planned Vanguard facility at INL; requires binding definitive agreements for pricing/quantity.
• Intellectual Property: Secured a Japanese patent allowance (September) covering multi-zone fuel elements and 3D printing methods.

Market and Competitive Outlook:

• Performance Targets: Lightbridge fuel designed to increase existing reactor power output by up to 10% (standard steam generators) or up to 20% (high-capacity steam generators); new-build reactors could see an increase of roughly one-third.
• Deployment Strategy: Focus on immediate market deployment by retrofitting existing fleets; asserts that global nuclear power growth prospects are at their strongest.
• Utility Engagement: Management believes utilities could make conditional commitments to host lead test assemblies before the completion of the full ATR loop irradiation program, contingent on satisfactory results from partial irradiation and post-examination data.

Macro / Industry Outlook:

• DOE Initiative Alignment: Aligned with the White House's UPRISE initiative targeting ~5 gigawatts (GW) of additional capacity from existing reactors.
• Growth Ambitions: Management advocates for tripling global nuclear power and quadrupling it in the U.S. by 2050, emphasizing the need for power from existing reactors to meet this demand.
• Regulatory Pathway: Pilot facility operates under DOE authorization; commercial use of fuel remains subject to separate NRC licensing and host utility approval.

Strategic Initiatives:

• Pilot Factory Construction: Planning and negotiations for agreements with INL and ENRIC are ongoing; construction requires additional DOE/INL authorizations (as of Sept 30, 2026, no material binding construction commitments were entered).
• Talent Expansion: Lightbridge Idaho Falls facility now holds the largest employee concentration; expect continued hiring of engineering and technical personnel to support the pilot factory and R&D.
• Infrastructure: Building a multipurpose R&D and manufacturing platform with a dedicated lab operating under NQA-1 nuclear quality assurance from the outset.
• Funding Strategy: Maintaining a disciplined, milestone-driven capital allocation strategy; currently utilizing ATM program ($91.4M remaining of $150M) as a liquidity source while evaluating other options.

Risks and Headwinds to Outlook:

• Regulatory & Authorization Delays: Pilot factory construction and operation are subject to "additional DOE and INL agreements, reviews, authorizations, and other prerequisites"; DOE authorization does not equate to NRC approval for commercial use.
• Capital Constraints: Development is a "multi-year investment" requiring significant additional capital; future funding is not guaranteed and depends on market conditions, government grants, or partnerships.
• Supply Chain Uncertainty: Long-term uranium feedstock (HALU) supply is still under discussion via non-binding MoUs; binding terms and pricing are not yet established.
• Technical Validation: Fuel performance depends on successful irradiation testing and validation of fuel performance models; results could alter licensing timelines.

Management Tone on the Future:

• Confidence Level: High confidence in the "strongest" global nuclear growth prospects and the efficacy of the "two-pronged" approach (pilot factory + commercial design).
• Progress Sentiment: Characterizes Q3 2026 as the "most significant advance to date" in the path from testing to commercial development.
• Discipline: Emphasizes a "disciplined approach" to capital expenditure and hiring, prioritizing efficiency and talent acquisition.

Miscellaneous:

• Facility Nomenclature: The pilot facility is now informally referred to as "SHED."
• Stock Comp: Significant increase in stock-based compensation recognized in Q3 due to new hires/bonuses, partially offset by reversals for milestones no longer deemed probable.